“Aducanumab” making a comeback in Alzheimer’s disease: An old wine in a new bottle-Reference-Cited by-同舟云学术

“Aducanumab” making a comeback in Alzheimer’s disease: An old wine in a new bottle

Published:2022-04 Issue: Volume:148 Page:112746
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Behl Tapan,Kaur Ishnoor,Sehgal Aayush,Singh Sukhbir,Sharma Neelam,Makeen Hafiz A.,Albratty Mohammed,Alhazmi Hassan A.,Felemban Shatha Ghazi,Alsubayiel Amal M.,Bhatia Saurabh,Bungau Simona

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference64 articles.

1. World Health Organization, Dementia, 2020, 〈https://www.who.int/news-room/fact942sheets/detail/dementia〉.

2. 2020 Alzheimer’s disease facts and figures;Alzheimer’s Association;Alzheimers Dement,2020

3. Alzheimer’s disease;Scheltens;Lancet,2021

4. Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990-2016: a systematic analysis 981 for the Global Burden of Disease Study 2016;Nichols;Lancet Neurol.,2019

5. Drugs for 984 Alzheimer’s disease: are they effective?;Casey;PT,2010

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides;Current Protein & Peptide Science;2024-09

2. Ultrasound Blood-Brain Barrier Opening and Aducanumab in Alzheimer’s Disease: A Systematic Review and Meta-Analysis;Cureus;2024-08-28

3. Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies;Signal Transduction and Targeted Therapy;2024-08-23

4. Minimally invasive nasal infusion (MINI) approach for CNS delivery of protein therapeutics: A case study with ovalbumin;Journal of Controlled Release;2024-08

5. Mitigation of CXCL10 secretion by metabolic disorder drugs in microglial-mediated neuroinflammation;Journal of Neuroimmunology;2024-06